.png/:/rs=w:768,m)
OUR MARKET HAS LED US TO AN IMPORTANT PIVOT
The need is greater now and we need to be a larger collaborative part of the genetic solutions to dependencies.
Mission and New Approach
After years of genetic sequencing analysis to detect dependencies and other genetic diseases, Genonto has evolved into a Think Tank with a much larger vision. Our goal is to organize new studies, trials and technologies on this problem with global collaborators, research institutions, universities and private enterprise.
What Led Us Here
From our inception with genetic sequencing, we focused on solutions for all types of dependencies - including opioids, alcohol, street drugs, etc. We have been fortunate to align with innovative hospitals and forward-thinking labs/clinics who think past traditional dependency programs and fight core issues with our human makeup that makes us susceptible to dependencies. Our solutions are quickly expanding into depression and many other diseases that affect our human health.
With the onset of the COVID-19 pandemic, we were tasked to align and collaborate with world-leading immunologists and doctors to introduce solutions to protect people through preventative, alternative and better programs to impact our society beneficially. This carried over to helping labs, clinics, hospitals and commercial companies seeking research to identify and prevent any negative health issues in the future.
Everything we do is patient centric.
Solutions
- Research and analysis to identify new genetic solutions and solve current problems
- Align with universities, hospitals, research institutions, and private enterprises globally to provide faster and larger positive impacts with healthcare innovations
- Genetic sequencing to identify predispositions and to provide positive impacts for these diseases (will expand past dependencies)
- Personalized strategies and education
Case Study
2020 was a great year and we expect continuous growth in 2021! Read our progress below.
Genonto - Case Study (pdf)
DownloadContact Us To Partner: brentm@genonto.com
